Norfloxacin PCD Pharma Franchise Company
Cafoli Lifecare is an established Norfloxacin PCD pharma franchise company in India, offering 10 Norfloxacin formulations across tablets, syrup and eye drops. All products are manufactured at WHO-GMP certified, DCGI-approved facilities, and franchise partners are granted exclusive district-wise monopoly rights across the full anti-infective range.
What is Norfloxacin?
Norfloxacin is a second-generation fluoroquinolone antibacterial. It inhibits the bacterial enzymes DNA gyrase and topoisomerase IV, which are essential for the replication, transcription and repair of bacterial DNA, giving it bactericidal activity against a broad range of Gram-negative organisms and some Gram-positive ones. Because it reaches high concentrations in the urine and the gut lumen, it is used principally for urinary tract and gastrointestinal infections, and topically as eye drops for bacterial conjunctivitis. Compound data is available on PubChem.
Available Norfloxacin Formulations
The Cafoli Lifecare Norfloxacin range comprises 10 formulations in the following dosage forms:
Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the current Norfloxacin price list.
Therapeutic Applications of Norfloxacin
Prescribed under medical supervision for:
- Uncomplicated and complicated urinary tract infections
- Bacterial gastroenteritis and traveller's diarrhoea
- Bacterial prostatitis
- Bacterial conjunctivitis and superficial ocular infections (eye drops)
- Paediatric gastrointestinal infection, as syrup, where clinically appropriate
Prescriber specialties: urologists, gastroenterologists, consulting physicians and paediatricians for the oral range; ophthalmologists for the ocular range. Norfloxacin is a prescription-only antibiotic and should be used in line with antimicrobial stewardship guidance, with attention to the known fluoroquinolone class warnings on tendon and neurological effects.
Why Norfloxacin is a High-Potential Molecule for Distributors
Norfloxacin's distinguishing commercial feature is channel reach. Very few anti-infectives let a distributor legitimately call on urology, general practice, paediatrics and ophthalmology with the same molecule — and each of those calls carries a different dosage form, so the same detailing visit generates several SKUs rather than one. Urinary and gastrointestinal infection are both extremely high-incidence, year-round conditions in India, and the diarrhoeal segment picks up sharply during the monsoon, giving the tablet business a predictable seasonal spike. The ophthalmic drops sell into a segment where pack values are low but repeat rates are high and competition on price is far less intense than in oral antibiotics. That combination of breadth, volume and a defensible niche form makes Norfloxacin an efficient volume-builder for a new franchise territory.
Why Choose Cafoli Lifecare
- Monopoly rights — exclusive district-wise marketing rights for the Norfloxacin range
- WHO-GMP certified manufacturing and DCGI-approved products
- Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
- 1000+ franchise partners across India with an on-time dispatch record
- Transparent net rates and dedicated franchise support
References
- PubChem — Norfloxacin compound record
- PubMed — Norfloxacin in urinary tract infection
- WHO Model List of Essential Medicines
Our formulations of Norfloxacin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: